SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report
SEC Accession No. 0001193125-06-236308
Filing Date
2006-11-15
Accepted
2006-11-15 17:21:01
Documents
3
Period of Report
2006-11-10
Filing Date Changed
2006-11-15
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d8k.htm 8-K 21626
2 SETTLEMENT AGREEMENT dex101.htm EX-10.1 35592
3 AGREEMENT dex102.htm EX-10.2 22681
  Complete submission text file 0001193125-06-236308.txt   81797
Mailing Address 5800 PARK OF COMMERCE BLVD NW STE 322 BOCA RATON FL 33487
Business Address 5800 PARK OF COMMERCE BLVD N W STE 322 BOCA RATON FL 33487 5619895800
NABI BIOPHARMACEUTICALS (Filer) CIK: 0000072444 (see all company filings)

IRS No.: 591212264 | State of Incorp.: DE | Fiscal Year End: 1225
Type: 8-K | Act: 34 | File No.: 000-04829 | Film No.: 061220806
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1